These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2884705

  • 1. Action of tulobuterol and fenoterol on the mucociliary clearance.
    Matthys H, Daikeler G, Krauss B, Vastag E.
    Respiration; 1987; 51(2):105-12. PubMed ID: 2884705
    [Abstract] [Full Text] [Related]

  • 2. Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease.
    Werdermann K.
    Lung; 1990; 168 Suppl():202-9. PubMed ID: 1974678
    [Abstract] [Full Text] [Related]

  • 3. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
    Morr H, Nink M, Ferlinz R.
    Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients suffering from a reversible bronchial obstruction.
    Maesen F, Smeets J, Polderman J.
    Arzneimittelforschung; 1983 Apr; 33(12):1696-8. PubMed ID: 6365104
    [Abstract] [Full Text] [Related]

  • 5. Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis.
    Patel KR.
    Lung; 1990 Apr; 168 Suppl():210-8. PubMed ID: 1974679
    [Abstract] [Full Text] [Related]

  • 6. Tulobuterol in the management of obstructive airways disease in adults.
    Patel KR.
    Clin Ther; 1985 Apr; 7(4):452-67. PubMed ID: 2861899
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Open cross-over comparison of tulobuterol and fenoterol in asthmatic adult patients.
    Sanchez J, Rivero A, Dal-Re R, Azanza JR.
    Int J Clin Pharmacol Res; 1988 Apr; 8(4):279-85. PubMed ID: 3182119
    [Abstract] [Full Text] [Related]

  • 9. Beta-agonistic properties of tulobuterol, a new beta-sympathicomimetic drug, and its effects on pulmonary beta-adrenoceptor characteristics.
    Terpstra GK, Raaijmakers JA.
    Lung; 1990 Apr; 168 Suppl():179-85. PubMed ID: 1974673
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subjects who never smoked.
    Vastag E, Matthys H, Köhler D, Gronbeck L, Daikeler G.
    Eur J Respir Dis Suppl; 1985 Apr; 139():93-100. PubMed ID: 3862617
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.
    Hochhaus G, Möllmann H.
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):342-62. PubMed ID: 1358833
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bronchial spasmolytic action of terbutaline and fenoterol compared with that of ipratropium bromide in the anaesthetized dog.
    Stepanek J.
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):308-28. PubMed ID: 152096
    [Abstract] [Full Text] [Related]

  • 16. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
    Kanehara M, Yokoyama A, Tomoda Y, Shiota N, Iwamoto H, Ishikawa N, Taooka Y, Haruta Y, Hattori N, Kohno N.
    Pulm Pharmacol Ther; 2008 Dec; 21(6):874-8. PubMed ID: 18983928
    [Abstract] [Full Text] [Related]

  • 17. [Metabolism of beta-adrenergic substances. Therapeutic implications].
    Brès J, Clauzel AM, Pistre MC, Rachmat H, Bressolle F.
    Bull Eur Physiopathol Respir; 1985 Dec; 21(5):19s-34s. PubMed ID: 2865990
    [Abstract] [Full Text] [Related]

  • 18. [Effect of beta-mimetics on bronchial mucus transport].
    Vastag E, Zsámboki G.
    Orv Hetil; 1985 Feb 10; 126(6):323-6. PubMed ID: 2983286
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of beta 2-agonists (in the light of fenoterol).
    Schmidt EW, Ulmer WT, Rominger KL.
    Respiration; 1995 Feb 10; 62(4):190-200. PubMed ID: 8578014
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
    Horiguchi T, Kondo R, Miyazaki J, Fukumokto K, Torigoe H.
    Arzneimittelforschung; 2004 Feb 10; 54(5):280-5. PubMed ID: 15212190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.